Dalacin and disease progression Patient Reports February 12, 2012

Dalacin Side Effects Report #5131807-3
Dalacin side effect was reported by a Health Professional from SWEDEN on Oct 02, 2006. Female patient, 63 years of age, was diagnosed with skin ulcer and was treated with Dalacin. After drug was administered, patient experienced the following side effects: disease progression, guillain-barre syndrome , hypoaesthesia, malaise, motor dysfunction. Dalacin dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, COZAAR, INSULATARD, PLENDIL, GLYBURIDE, GLUCOPHAGE, TROMBYL. Patient was hospitalized. Patient recovered.

Dalacin Side Effects Report #5875846-3
Dalacin side effect was reported by a Consumer or non-health professional from JAPAN on Aug 28, 2008. Male patient, 60 years of age, weighting 108.2 lb, was diagnosed with pulmonary embolism , endophthalmitis and was treated with Dalacin. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood pressure decreased, c-reactive protein increased, disease progression, glucose urine present, glycosylated haemoglobin increased, heart rate increased, hyperkalaemia, hyponatraemia. Dalacin dosage: unknown. During the same period patient was treated with DIFLUCAN, INSULIN. Patient recovered.

Dalacin Side Effects Report #6055830-X
Dalacin side effect was reported by a Pharmacist from JAPAN on Jan 15, 2009. Female patient, 80 years of age, was diagnosed with pneumonia  and was treated with Dalacin. After drug was administered, patient experienced the following side effects: disease progression, lip swelling, stomatitis. Dalacin dosage: 600 MG, 2X/DAY. During the same period patient was treated with GLUCOSE W, DAIMON, CHARCOAL, NORVASC, ALLOPURINOL, LANSOPRAZOLE, FRANDOL, LASIX. Patient died.

Dalacin Side Effects Report #5133081-0
Dalacin side effect was reported by a Physician from JAPAN on Oct 04, 2006. Male patient, 67 years of age, was diagnosed with infection  and was treated with Dalacin. After drug was administered, patient experienced the following side effects: ascites, disease progression, gastrointestinal necrosis, meningitis , mucormycosis, peritonitis, pseudomembranous colitis. Dalacin dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with MEROPEN, MICAFUNGIN, PREDNISOLONE. Patient died on 01/01/2005.